The vaccines are set to cross the border by truck. They are the primary doses to be manufactured and shipped to this nation from south of the border.
A panel of scientific consultants beneficial pausing using the AstraZeneca-Oxford vaccine amongst individuals underneath the age of 55 yesterday as a precautionary measure over considerations the vaccine could also be linked to uncommon however extreme situations of blood clots in some immunized sufferers — notably amongst youthful ladies.
The advice marked the third time the Nationwide Advisory Committee on Immunization (NACI) altered its steerage on the vaccine previously month, elevating fears that altering tips could contribute to vaccine hesitancy.
Dr. Shelley Deeks, the vice-chair of NACI, mentioned the advice got here in response to new information from Europe that implies the danger of extreme blood clots is now doubtlessly as much as one in 100,000 — a lot increased than the one in a single million danger believed earlier than.
Well being Canada mentioned Monday it ordered AstraZeneca to conduct an in depth examine on the dangers and advantages of its COVID-19 vaccine throughout a number of age teams and by intercourse. NACI’s suggestion will stay in place whereas that examine is accomplished.
WATCH: AstraZeneca steerage change ‘precautionary,’ says federal authorities adviser
Over 300,000 AstraZeneca-Oxford pictures have been administered in Canada already, with no experiences of blood clots right here, officers mentioned.
Prime Minister Justin Trudeau, Procurement Minister Anita Anand and Well being Minister Patty Hajdu scheduled a information convention for 11:30 a.m. ET to talk to Canadians about COVID-19 and the vaccine rollout.
Chief Public Well being Officer Dr. Theresa Tam and Deputy Chief Public Well being Officer of Canada Dr. Howard Njoo are additionally anticipated to be in attendance.
Barely lower than 3.3 million doses of COVID-19 vaccine are anticipated to reach this week in complete, with Pfizer-BioNTech additionally delivery nearly 1.2 million doses and Moderna anticipated to make good on a cargo of 590,400 doses that was delayed final week by a backlog within the firm’s high quality assurance course of.